This brand name is authorized in Austria, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, United States
The drug LUTATHERA contains one active pharmaceutical ingredient (API):
1
Lutetium ¹⁷⁷Lu oxodotreotide
UNII AE221IM3BB - LUTETIUM OXODOTREOTIDE LU-177
|
Lutetium (177Lu) oxodotreotide has a high affinity for subtype 2 somatostatin receptors (sst2). It binds to malignant cells which overexpress sst2 receptors. Lutetium-177 (177Lu) is a βemitting radionuclide with a maximum penetration range in tissue of 2.2 mm (mean penetration range of 0.67 mm), which is sufficient to kill targeted tumour cells with a limited effect on neighbouring normal cells. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
LUTATHERA Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
LUTATHERA Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V10XX04 | V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals → V10XX Various therapeutic radiopharmaceuticals | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1617184 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1171226001 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60823764 |
Country: HK | Department of Health Drug Office | Identifier(s): 66645, 66646 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8801 |
Country: IT | Agenzia del Farmaco | Identifier(s): 045677010 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4291458A1020 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1084163 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100396207 |
Country: US | FDA, National Drug Code | Identifier(s): 69488-003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.